Variants in Apaf-1 segregating with major depression promote apoptosome function.

Area of Science:

• Genetics
• Molecular Biology
• Neuroscience

Background:

• The APAF1 gene encodes apoptosis protease activating factor 1 (Apaf-1).
• APAF1 has been identified as a chromosome 12 gene associated with major depression predisposition in humans.
• Understanding the functional impact of APAF1 variants is crucial for elucidating the genetic underpinnings of major depression.

Purpose of the Study:

• To determine the molecular and cellular phenotypes of APAF1 variants.
• To investigate whether APAF1 alleles associated with major depression share a common functional phenotype.
• To explore the potential role of enhanced apoptosis in the etiology of major depression.

Main Methods:

• In vitro reconstruction of the apoptosome complex to assess Apaf-1's ability to activate caspase 9.
• Yeast heterologous expression assay to measure cellular phenotypes of Apaf-1 variants.
• Analysis of APAF1 alleles segregating with major depression in families linked to chromosome 12.

Main Results:

• Apaf-1 variants encoded by APAF1 alleles associated with major depression demonstrated a common gain-of-function phenotype in both in vitro and cellular assays.
• Other Apaf-1 variants exhibited neutral or loss-of-function phenotypes.
• A clear distinction in functional phenotype was observed between depression-associated and non-associated APAF1 variants.

Conclusions:

• The gain-of-function phenotype of depression-associated APAF1 variants suggests a specific molecular mechanism contributing to major depression.
• Enhanced apoptosis, mediated by these variants, is implicated as an etiological factor in major depression.
• These findings highlight the importance of apoptosis regulation in the context of major depressive disorder.